TaiGen Initiates Phase II Trial Of Nemonoxacin For Treatment Of Adult Community Acquired Pneumonia (CAP)
Tue, 09 Jan 2007 08:00 AM EST
... TaiGen Biotechnology Inc. announced today that the company has started enrollment of patients for the Phase II clinical trial of Nemonoxacin (TG-873870) for the treatment of adult community acquired pneumonia (CAP). [click link for full article] ...
Related Topics
- Community Acquired Pneumonia
- Pneumonia
- Clinical Trials
- MRSA
- Community Outreach
- Older Adults
- Community Health
- Community Development
- Hydrocephalus
- Apraxia
- RSV
- Acquired Immune Deficiency Syndrome
- Community and Faith-Based Initiatives
- Faith-Based and Community Initiatives
- Retirement
- Incontinence
- Children Of Alcoholics
- Nystatin and Triamcinolone
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1

Not Signed In -


